z-logo
open-access-imgOpen Access
Encapsulating peritoneal sclerosis
Author(s) -
Sayed M. Habib,
Alferso C Abrahams,
S. Mechiel Korte,
Marian C. Clahsenvan Groningen,
Michiel G.H. Betjes,
Deirisa Lopes Barreto,
D. G. Struijk,
R. T. Krediet,
Amélie Dendooven,
Dionne M. van der Giezen,
Kendra Garchow,
Raechel J. Toorop,
Christopher J.E. Watson,
Walther H. Boer,
Bruce L. Riser,
Tri Q. Nguyen,
Joerg Latus,
Péter Fritz,
Christoph Ulmer,
S. Segerer,
Mark Dominik Alscher,
N. Braun,
Shigehisa Aoki,
J. Makino,
M. Noguchi,
Shuji Toda,
Rukshana Shroff,
Constantinos J. Stefanidis,
A. Edifonti,
Mesiha Ekim,
Gema Ariceta,
Sevcan A. Bakkaloğlu,
Michel Fischbach,
Günter Klaus,
Aleksandra Żurowska,
Claus Peter Schmitt,
Alan R. Watson
Publication year - 2013
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gft135
Subject(s) - medicine , multiple sclerosis , peritoneal dialysis , immunology
Chronic peritoneal dialysis (PD) can be complicated by encapsulating peritoneal sclerosis (EPS), a rare but the most severe complication associated with long-term PD. Morbidity and mortality are still high (range from 25% to 55%) especially in the first year after diagnosis. The international Society for Peritoneal Dialysis (ISPD) defined EPS by clinical signs of abdominal pain, bowel obstruction or weight loss in late stages of the disease. Clinical symptoms, radiologic findings and histologic criteria are the three diagnostic pillars.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom